201 related articles for article (PubMed ID: 32291398)
1. Papillary thyroid carcinoma with prominent myofibroblastic stromal component: clinicopathologic, immunohistochemical and next-generation sequencing study of seven cases.
Suster D; Michal M; Nishino M; Piana S; Bongiovanni M; Blatnik O; Hájková V; Ptáková N; Michal M; Suster S
Mod Pathol; 2020 Sep; 33(9):1702-1711. PubMed ID: 32291398
[TBL] [Abstract][Full Text] [Related]
2. CTNNB1 mutations in papillary thyroid carcinoma with prominent myofibroblastic stromal component.
Roukain A; Sykiotis GP
Mod Pathol; 2021 Nov; 34(11):2087-2088. PubMed ID: 33846546
[No Abstract] [Full Text] [Related]
3. Papillary thyroid carcinoma with nodular fasciitis-like stroma and β-catenin mutations should be renamed papillary thyroid carcinoma with desmoid-type fibromatosis.
Rebecchini C; Nobile A; Piana S; Sarro R; Bisig B; Gerasimos SP; Saglietti C; Matter M; Marino L; Bongiovanni M
Mod Pathol; 2017 Feb; 30(2):236-245. PubMed ID: 27713418
[TBL] [Abstract][Full Text] [Related]
4. SOX11 expression in a case of papillary thyroid carcinoma with fibromatosis/fasciitis-like stroma containing BRAF c.1799_1801delTGA and CTNNB1 c.133T>C mutations.
Wong SBJ; Nga ME; Michal M; Vanecek T; Seet JE; Petersson F
Virchows Arch; 2019 Oct; 475(4):519-525. PubMed ID: 31327063
[TBL] [Abstract][Full Text] [Related]
5. Papillary thyroid carcinoma with desmoid-type fibromatosis: A clinical, pathological, and immunohistochemical study of 14 cases.
Takada N; Hirokawa M; Ito M; Ito A; Suzuki A; Higuchi M; Kuma S; Hayashi T; Kishikawa M; Horikawa S; Miyauchi A
Endocr J; 2017 Oct; 64(10):1017-1023. PubMed ID: 28794344
[TBL] [Abstract][Full Text] [Related]
6. High expression and localization of β-catenin and epidermal growth factor receptor identify high risk papillary thyroid carcinoma patients.
Išić Denčić T; Bartolome A; Šelemetjev S; Đorić I; Tatić S; Živaljević V; Cvejić D
Exp Mol Pathol; 2018 Oct; 105(2):181-189. PubMed ID: 30077672
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical and Molecular Analyses Focusing on Mesenchymal Cells in Papillary Thyroid Carcinoma with Desmoid-Type Fibromatosis.
Takada N; Mussazhanova Z; Hirokawa M; Nakashima M; Miyauchi A
Pathobiology; 2018; 85(5-6):300-303. PubMed ID: 30223266
[TBL] [Abstract][Full Text] [Related]
8. Papillary thyroid carcinoma with desmoid-type fibromatosis: the clinicopathological features with characteristic imaging and molecular correlation requiring comprehensive treatment.
Huang H; Li L; Liu X; Zhao L; Cui Z; Zhang R; Chen S
Hum Pathol; 2023 Jun; 136():84-95. PubMed ID: 37019411
[TBL] [Abstract][Full Text] [Related]
9. Papillary thyroid carcinoma with nodular fasciitis-like stroma: a usual entity with distinctive morphology.
Ginter PS; Scognamiglio T
Int J Surg Pathol; 2015 Jun; 23(4):305-7. PubMed ID: 25663334
[TBL] [Abstract][Full Text] [Related]
10. PD-L1 and thyroid cytology: A possible diagnostic and prognostic marker.
Dell'Aquila M; Granitto A; Martini M; Capodimonti S; Cocomazzi A; Musarra T; Fiorentino V; Pontecorvi A; Lombardi CP; Fadda G; Pantanowitz L; Larocca LM; Rossi ED
Cancer Cytopathol; 2020 Mar; 128(3):177-189. PubMed ID: 31821747
[TBL] [Abstract][Full Text] [Related]
11. GLIS Rearrangement is a Genomic Hallmark of Hyalinizing Trabecular Tumor of the Thyroid Gland.
Nikiforova MN; Nikitski AV; Panebianco F; Kaya C; Yip L; Williams M; Chiosea SI; Seethala RR; Roy S; Condello V; Santana-Santos L; Wald AI; Carty SE; Ferris RL; El-Naggar AK; Nikiforov YE
Thyroid; 2019 Feb; 29(2):161-173. PubMed ID: 30648929
[TBL] [Abstract][Full Text] [Related]
12. Cribriform-Morular Variant of Papillary Thyroid Carcinoma With Poorly Differentiated Features: A Case Report With Immunohistochemical and Molecular Genetic Analysis.
Corean J; Furtado LV; Kadri S; Segal JP; Emerson LL
Int J Surg Pathol; 2019 May; 27(3):294-304. PubMed ID: 30176755
[TBL] [Abstract][Full Text] [Related]
13. Papillary carcinoma of the thyroid gland forming a myofibroblastic nodular tumor: report of two cases and review of the literature.
Naganuma H; Iwama N; Nakamura Y; Ohtani N; Ohtani H; Takaya K; Sakai N
Pathol Int; 2002 Jan; 52(1):54-8. PubMed ID: 11940207
[TBL] [Abstract][Full Text] [Related]
14. Papillary Thyroid Carcinoma BRAF Immunopositivity.
Erickson LA; Chen B
Mayo Clin Proc; 2021 Jan; 96(1):267-268. PubMed ID: 33413831
[No Abstract] [Full Text] [Related]
15. Therapeutic potential of Dickkopf-1 in wild-type BRAF papillary thyroid cancer via regulation of β-catenin/E-cadherin signaling.
Cho SW; Kim YA; Sun HJ; Ahn HY; Lee EK; Yi KH; Oh BC; Park DJ; Cho BY; Park YJ
J Clin Endocrinol Metab; 2014 Sep; 99(9):E1641-9. PubMed ID: 24848709
[TBL] [Abstract][Full Text] [Related]
16. β-Catenin Attenuation Inhibits Tumor Growth and Promotes Differentiation in a BRAF
Zou M; BinEssa HA; Al-Malki YH; Al-Yahya S; Al-Alwan M; Al-Jammaz I; Khabar KSA; Almohanna F; Assiri AM; Meyer BF; Alzahrani AS; Al-Mohanna FA; Shi Y
Mol Cancer Ther; 2021 Sep; 20(9):1603-1613. PubMed ID: 34224366
[No Abstract] [Full Text] [Related]
17. Immunohistochemical detection of the BRAF V600E-mutated protein in papillary thyroid carcinoma.
Koperek O; Kornauth C; Capper D; Berghoff AS; Asari R; Niederle B; von Deimling A; Birner P; Preusser M
Am J Surg Pathol; 2012 Jun; 36(6):844-50. PubMed ID: 22592144
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemistry with the anti-BRAF V600E (VE1) antibody: impact of pre-analytical conditions and concordance with DNA sequencing in colorectal and papillary thyroid carcinoma.
Dvorak K; Aggeler B; Palting J; McKelvie P; Ruszkiewicz A; Waring P
Pathology; 2014 Oct; 46(6):509-17. PubMed ID: 25014730
[TBL] [Abstract][Full Text] [Related]
19. The expression of monocarboxylate transporters in thyroid carcinoma can be associated with the morphological features of BRAF
Rossi ED; Bizzarro T; Granja S; Martini M; Capodimonti S; Luca E; Fadda G; Lombardi CP; Pontecorvi A; Larocca LM; Baltazar F; Schmitt F
Endocrine; 2017 May; 56(2):379-387. PubMed ID: 27484771
[TBL] [Abstract][Full Text] [Related]
20. [Clinicopathologic and molecular features of cribriform morular variant of papillary thyroid carcinoma].
Cui XJ; Zhao HO; Su P; Chen J; Zhang RY; Pan Y; Ouyang XM; Liu J; Zhang JQ; Yang Y; Yang R; Ding L; Liu ZY
Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):354-359. PubMed ID: 29783802
[No Abstract] [Full Text] [Related]
[Next] [New Search]
